Probing the role of interfacial residues in a dimerization inhibitor of HIV-1 protease

Bioorganic and Medicinal Chemistry Letters

Volumn 9, Issue 16, 1999, Pages 2431-2436

  Shultz, Michael D ^a   Chmielewski, Jean ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ENZYME INHIBITOR; PROTEINASE;

ARTICLE; CHEMICAL ANALYSIS; CROSS LINKING; DIMERIZATION; ENZYME INHIBITION; VIRUS REPLICATION;

ALANINE; AMINO ACID SUBSTITUTION; DIMERIZATION; HIV PROTEASE INHIBITORS; HIV-1;

EID: 0033575743     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(99)00400-X     Document Type: Article

References (33)

1. (a) Rana K. Z.; Dudley M. N. Pharmacotherapy 1999, 19, 35.
2. (b) Chrusciel, R. A.; Romines, K. R. Expert Opin. Ther. Pat., 1997, 7, 111.
3. (c) Wlodawer, A.; Vondrasek, J. Annu. Rev. Biophys. Biomol. Struct. 1998, 27, 249.
4. Krausslich, H. G.; Wimmer, E. Annu. Rev. Biochem. 1988, 57, 701.
5. (a) Wlodawer, A.; Miller, M.; Jaskolski, M.; Sathyanarayana, B. K.; Baldwin, E.; Weber, I. T.; Selk, L. M.; Clawson, L.; Schneider, J.; Kent, S. B. Science 1989, 245, 616.
6. (b) Meek, T. D.; Dayton, B. D.; Metcalf, B. W.; Dreyer, G. B.; Strickler, J. E.; Gorniak, J. G.; Rosenberg, M.; Moore, M. L.; Magaard, V. W.; Debouck, C. Proc. Natl. Acad. Sci. U. S. A. 1989, 86, 1841.
7. (a) Ridky, T. W.; Kikonyogo, A.; Leis, J.; Gulnik, S.; Copeland, T.; Erickson, J.; Wlodawer, A.; Kurinov, I.; Harrison, R. W.; Weber, I. T. Biochemistry. 1998, 37, 13835.
8. (b) Luque, I.; Todd, M. J.; Gomez, J.; Semo, N.; Freire, E. Biochemistry. 1998, 37, 5791.
9. (c) Zhang, Y.-M; Imamichi, H.; Imamichi, T.; Lane, H.C.; Falloon, J.; Vasudevachari, M.B.; Salzman, N. P. J. Virol. 1997, 71, 6662.
10. (d) Lin, Y.; Lin, X.; Hong, L.; Foundling, S.; Heinrikson, R. L.; Thaisrivongs, S.; Leelamanit, W.; Raterman, D.; Shah, M.; Dunn, B. M.; Tang, J. Biochemistry. 1995, 34, 1143.
11. (e) Carr, A.; Samaras, K.; Burton, S.; Law, M.; Freund, J.; Chisholm, D. J.; Cooper, D. A. AIDS 1998, 12, F51-8.
12. (f) Miller, K. D.; Jones, E.; Yanovski, J. A.; Shankar, R.; Feuerstein, I.; Falloon, J. Lancet 1998, 351, 875.
13. (g) Viraben, R.; Aquilina, C. AIDS 1998, 12, F37-9.
14. (h) Herry, I.; Bernard, L.; de Truchis, P.; Perronne, C. Clin. Infect. Dis. 1997, 25, 937
15. (i) Carr, A.; Samaras, K.; Chisholm, D. J.; Cooper, D. A. Lancet 1998, 351, 1881.
16. Zutshi, R.; Brickner, M.; Chmielewski, J. Curr. Opin. Chem. Biol. 1998, 2, 62.
17. Gustchina, A.; Weber, I. T. Proteins: Struct. Funct. Genetics 1991, 10, 325.
18. (a) Zutshi, R.; Franciskovich, J.; Shultz, M.; Schweitzer, B.; Bishop, P.; Wilson, M.; Chmielewski, J. J. Am. Chem. Soc. 1997, 119, 4841.
19. (b) Ulysse, L. G.; Chmielewski, J. Bioorg Med Chem Lett 1998, 8, 3281.
20. (c) Shultz, M. D.; Chmielewski, J.; Tetrahedron: Asymmetry 1997, 8, 3881.
21. (d) Zutshi, R.; Shultz M. D.; Ulysse, L.; Bishop, P.; Schweitzer, B.; Vogel, K.; Franciskovich, M.; Wilson, M.; Chmielewski, J.; Synlett 1998, 104.
22. (e) Babé, L. M.; Rosé, J.; Craik, C. S. Protein Sci. 1992, 1, 1244.
23. (a) Schramm, H. J.; Nakashima, H.; Schramm, W.; Wkayame, H.; Yamamoto N. Biochem. Biophys. Res. Comm. 1991, 179, 847.
24. (b) Schramm, H. J.; Hansen, J.; Breipohl, G.; Henke, S.; Jaeger, E.; Meichsner, C.; Rieb, G.; Ruppert, D.; Rucknagel, K.-P.; Schafer, W.; Schramm, W. Bioch. Biophys. Res. Comm. 1992, 184, 980.
25. (c) Schramm, H. J.; Billich, A.; Jaeger, E.; Rucknagel, K.-P.; Arnold, G.; Schramm, W. Biocem. Biophys. Res. Comm. 1993, 194, 595.
26. (d) Schramm, H. J.; Boetzel, J.; Buttner, J.; Fritsche, E.; Gohring, W.; Jaeger, E.; Konig, S.; Thumfart, O.; Wenger, T.; Nagel, N. E.; Schramm, W. Antiviral Research 1996, 30, 155.
27. Clackson, T.; Wells, J. A. Science 1995, 267, 383.
28. Wang, S. S. J. Am. Chem. Soc., 1983, 95, 1328.
29. Mass spectral data for compounds: (Table presented)
30. Toth, M. V.; Marshall, G. R. Int. J. Peptide Protein Res., 1990, 36, 544.
31. Todd, M. J.; Semo, N.; Freire, E. J. Mol. Biol. 1998, 283, 475.
32. Miller, S.; Lesk, A. M.; Janin, J.; Chothia, C. Nature 1987, 328, 834.
33. All computations were done using the Macromodel software package. (Mohamadi, F.; Richards, N. G. J.; Guida, W. C.; Liskamp, R.; Lipton, M.; Caufield, C.; Chang, G.; Hendrickson, T.; Still, W. C. J. Comput. Chem. 1990, 112, 6127). To determine the surface area exposed with each mutation, a 1.4 Å sphere was rolled around the dimer before and after the requisite side chain was replace by alanine.